{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Budesonide风险",
            "expectation": "若风险成立，进一步验证对假设有效性的影响",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Mesalamine风险",
            "expectation": "验证风险是否显著影响假设的有效性",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pentasa",
          "type": "Drug",
          "label": "Pentasa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sulfasalazine",
          "type": "Drug",
          "label": "Sulfasalazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofacitinib",
          "type": "Drug",
          "label": "Tofacitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mercaptopurine",
          "type": "Drug",
          "label": "Mercaptopurine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg",
          "type": "Target",
          "label": "TNF-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pb",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_gastrointestinal_barrier_disorders",
          "type": "Disease",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_budesonide",
          "type": "Target",
          "label": "OffTargetBudesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_budesonide",
          "type": "Pathway",
          "label": "RiskPathBudesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_budesonide",
          "type": "Phenotype",
          "label": "AdverseEffectBudesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_mesalamine",
          "type": "Target",
          "label": "OffTargetMesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_mesalamine",
          "type": "Pathway",
          "label": "RiskPathMesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_mesalamine",
          "type": "Phenotype",
          "label": "AdverseEffectMesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Pentasa",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Sulfasalazine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Tofacitinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Mercaptopurine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_budesonide",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知对炎症反应有抑制作用"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "同类药理作用"
        },
        {
          "source": "drug_pentasa",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于相应疾病的临床证据"
        },
        {
          "source": "drug_sulfasalazine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于治疗肠道炎症"
        },
        {
          "source": "drug_prednisone",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，有效于炎症"
        },
        {
          "source": "drug_infliximab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向TNF-alpha，有效抑制炎症"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向TNF-alpha，有效抑制炎症"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "作用于特定的免疫通路"
        },
        {
          "source": "drug_tofacitinib",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "口服的JAK抑制剂，有调节作用"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制剂，影响炎症过程"
        },
        {
          "source": "drug_mercaptopurine",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制及抗炎作用"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_pb",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "针对活化的淋巴细胞，调节炎症过程"
        },
        {
          "source": "n_tg",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "TNF-alpha 在炎症通路中起关键作用"
        },
        {
          "source": "n_pb",
          "target": "d_gastrointestinal_barrier_disorders",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路与肠道屏障疾病密切相关"
        },
        {
          "source": "drug_budesonide",
          "target": "n_ot_budesonide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在旁路效应"
        },
        {
          "source": "n_ot_budesonide",
          "target": "n_rp_budesonide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_budesonide",
          "target": "n_adv_budesonide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_adv_budesonide",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，将削弱假设的有效性"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_ot_mesalamine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "同样可能存在旁路"
        },
        {
          "source": "n_ot_mesalamine",
          "target": "n_rp_mesalamine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险路径相关"
        },
        {
          "source": "n_rp_mesalamine",
          "target": "n_adv_mesalamine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "产生不良表型"
        },
        {
          "source": "n_adv_mesalamine",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险对假设产生反驳"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "set_weights": [
            {
              "edge_id": "e_refutes_budesonide",
              "weight": 0.85,
              "rationale": "若存在副作用风险将直接削弱疗效假设"
            },
            {
              "edge_id": "e_rp_budesonide",
              "weight": 0.8,
              "rationale": "风险通路的存在可能影响正常药物作用"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Budesonide安全性",
              "pro_nodes": [
                "drug_budesonide"
              ],
              "con_nodes": [
                "n_adv_budesonide"
              ],
              "note": "药物的潜在副作用与疗效冲突"
            }
          ]
        },
        "notes": "已完成 Budeonide 的安全性压力测试，并评估对假设的影响"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "set_weights": [
            {
              "edge_id": "e_refutes_mesalamine",
              "weight": 0.85,
              "rationale": "潜在不良效果的存在将削弱有效性假设"
            },
            {
              "edge_id": "e_rp_mesalamine",
              "weight": 0.8,
              "rationale": "可能的不良反应路径影响药物的正向作用"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Mesalamine安全性",
              "pro_nodes": [
                "drug_mesalamine"
              ],
              "con_nodes": [
                "n_adv_mesalamine"
              ],
              "note": "药物的副作用与预期疗效相悖"
            }
          ]
        },
        "notes": "完成 Mesalamine 的安全性压力测试，并分析其对假设的影响"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "潜在副作用对两种药物（Budesonide 和 Mesalamine）的效益评估冲突仍需解决"
    ]
  }
}